EDIT
Editas Medicine Inc
2.60$
+4.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,126.0% | 2,988.3% | 2,789.0% | 559.2% | 324.7% | 720.6% | 542.4% | 443.8% | 120.1% | 534.7% | 765.7% | 1,011.4% | 590.0% | 283.2% | 604.1% | 260.6% | 54.0% | 538.6% | 645.3% | 8,905.8% | 472.2% | 301.2% | 560.9% | 686.2% | 98,395.2% | 795.6% | 383.8% | 1,031.5% | 28.4% | 2.4% | 124.1% | 276.8% | 2,621.3% | 158.8% | 570.9% | 452.2% | 262.2% | 3.3% | 17.1% | – | – | |
| -1,026.0% | -2,888.3% | -2,689.0% | -459.2% | -224.7% | -620.6% | -442.4% | -343.8% | -20.1% | -434.7% | -665.7% | -911.4% | -490.0% | -183.2% | -504.1% | -160.6% | 46.0% | -438.6% | -545.3% | -8,805.8% | -372.2% | -201.2% | -460.9% | -586.2% | -98,295.2% | -695.6% | -283.8% | -931.5% | 71.6% | 97.6% | -24.1% | -176.8% | -2,521.3% | -58.8% | -470.9% | -352.2% | -162.2% | 100.0% | 82.9% | 100.0% | 56.9% | |
| 1,126.0% | 2,988.3% | 2,789.0% | 559.2% | 324.7% | 720.6% | 542.4% | 443.8% | 120.1% | 313.7% | 765.7% | 1,011.4% | 590.0% | 283.2% | 604.1% | 260.6% | 54.0% | 538.6% | 645.3% | 8,905.8% | 472.2% | 301.2% | 560.9% | 686.2% | 98,395.2% | 795.6% | 383.8% | 1,031.5% | 100.0% | 113.4% | 4,174.3% | 10,290.4% | 78,096.7% | 158.8% | 570.9% | 452.2% | 262.2% | 110.8% | 100.0% | 169.7% | 149.3% | |
| 1,174.1% | 1,452.9% | 1,801.8% | 384.0% | 201.1% | 373.2% | 361.2% | 194.1% | 91.8% | 215.3% | 845.3% | 618.6% | 408.9% | 137.7% | 310.5% | 131.0% | 31.7% | 138.3% | 330.0% | 5,811.9% | 261.2% | 132.5% | 288.7% | 266.2% | 38,657.1% | 275.2% | 233.6% | 595.8% | 280.9% | 24.1% | 1,703.9% | 3,548.9% | 29,652.5% | 53.4% | 287.1% | 359.4% | 163.3% | 45.9% | 361.5% | 97.6% | 96.8% | |
| 2,300.1% | 4,441.2% | 4,590.8% | 943.2% | 525.8% | 1,093.8% | 903.6% | 637.9% | 212.0% | 529.0% | 1,611.0% | 1,630.0% | 998.9% | 137.7% | 310.5% | 131.0% | 31.7% | 138.3% | 330.0% | 5,811.9% | 261.2% | 132.5% | 288.7% | 266.2% | 38,657.1% | 275.2% | 233.6% | 595.8% | 1,011.7% | 137.5% | 5,878.1% | 13,839.4% | 105,127.9% | 93.4% | 1,164.2% | 1,088.3% | 163.3% | 156.7% | 966.1% | 256.0% | 231.6% | |
| -2,200.1% | -4,341.2% | -4,490.8% | -843.2% | -425.8% | -993.8% | -803.6% | -537.9% | -112.0% | -429.0% | -1,511.0% | -1,530.0% | -898.9% | -320.9% | -814.5% | -291.6% | 14.3% | -576.9% | -875.3% | -14,617.7% | -633.4% | -333.7% | -749.5% | -852.5% | -136,952.4% | -970.7% | -517.3% | -1,527.3% | -940.1% | -39.9% | -5,902.3% | -14,016.2% | -107,649.2% | -152.2% | -1,635.1% | -1,440.6% | -325.4% | -56.7% | -883.2% | -156.0% | -174.7% | |
| 14.8% | 39.8% | 89.4% | 14.4% | 0.7% | 3.4% | 11.2% | 10.6% | 7.1% | 19.6% | 99.4% | 82.9% | 43.7% | 13.4% | 27.2% | 5.5% | 0.4% | 18.8% | 2.1% | 38.5% | 2.5% | 15.3% | 3.5% | 12.3% | 4,271.4% | 21.7% | 35.2% | – | – | 5.8% | 0.0% | 0.0% | 0.0% | – | 47.6% | 56.5% | 31.8% | 26.8% | 37.9% | 8.9% | 23.8% | |
| -2,185.0% | -4,384.9% | -4,559.7% | -853.7% | -423.4% | -986.9% | -787.9% | -525.3% | -105.0% | -409.4% | -1,413.7% | -1,450.0% | -856.1% | -307.5% | -659.2% | -219.3% | 12.4% | -547.3% | -872.9% | -14,579.4% | -630.7% | -332.3% | -746.0% | -840.2% | -132,681.0% | -929.3% | -497.8% | -1,395.6% | -843.7% | -31.4% | -5,458.1% | -13,178.8% | -101,870.5% | -148.3% | -1,633.5% | -1,487.8% | -333.0% | -22.7% | -882.4% | -153.3% | -157.3% | |
| -43.7% | -18.5% | 89.4% | 14.4% | -7.0% | -19.4% | -11.2% | -19.1% | -7.1% | -34.1% | -131.9% | -115.5% | -43.7% | -19.7% | 86.9% | -5.5% | -2.1% | -14.9% | -20.0% | -486.3% | -2.5% | -16.1% | -3.5% | -12.3% | -4,271.4% | -87.3% | -35.2% | -185.3% | -28.4% | 17.2% | 0.0% | – | 3,157.4% | – | – | – | – | – | – | – | – | |
| -2,185.0% | -4,384.9% | -4,559.7% | -853.7% | -423.4% | -986.9% | -787.9% | -525.3% | -105.0% | -409.4% | -1,413.7% | -1,450.0% | -856.1% | -307.5% | -659.2% | -219.3% | 12.4% | -547.3% | -872.9% | -14,579.4% | -630.7% | -332.3% | -746.0% | -840.2% | -132,681.0% | -929.3% | -497.8% | -1,395.6% | -843.7% | -31.4% | -5,458.1% | -13,178.8% | -101,870.5% | -148.3% | -1,633.5% | -1,487.8% | -333.0% | -22.7% | -882.4% | -153.3% | -157.3% | |
| -2,170.9% | -4,290.8% | -4,398.2% | -822.2% | -414.9% | -967.3% | -784.5% | -535.9% | -106.2% | -414.7% | -1,480.6% | -1,500.3% | -880.0% | -314.6% | -800.6% | -283.4% | 16.1% | -566.5% | -857.4% | -14,265.7% | -611.5% | -320.2% | -723.0% | -815.1% | -128,861.9% | -905.2% | -482.1% | -1,342.2% | -815.3% | -29.0% | -5,334.0% | -12,901.9% | -99,249.2% | -107.8% | -1,544.8% | -1,380.1% | -291.6% | -21.3% | -827.5% | -164.2% | -149.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.